Real-world Study of Aflibercept 8 mg in nAMD

Clinical trial NCT07640997 · RECRUITING

Trial details

NCT number: NCT07640997
Sponsor: Peking University People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Neovascular Age-Related Macular Degeneration (nAMD)

Start date: 2025-11-11
Primary completion: 2027-08-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.